Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b

Journal of Hepatology

Volumn 26, Issue 4, 1997, Pages 935-939

  Krüger, Martin ^a   Böker, Klaus H W ^a   Zeidler, Henning ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

famciclovir; hepatitis B; interferon alfa; nucleoside analog; polyarteritis nodosa

Indexed keywords

ALPHA2B INTERFERON; FAMCICLOVIR; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TOLERANCE; HEPATITIS B; HUMAN; MALE; ORAL DRUG ADMINISTRATION; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS HEPATITIS;

EID: 0342506489     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80263-2     Document Type: Article

References (23)

1. Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB, Wallace SL. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 33:1990;1088-1093.
2. Guillevin L, Lhote F, Jarrousse B, Bironne P, Barrier J, Deny P, Trepo C, Kahn MF, Godeau P. Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Med Intern Paris. 1:1992;63-74.
3. Shusterman N, London W. Hepatitis B and immune complex disease. N Engl J Med. 310:1984;43-46.
4. Genereau T, Lortholary O, Leclerq P, Grenet D, Tubery M, Sicard D, Caubarrere I, Guillevin L. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients. Br J Rheumatol. 33:1994;959-962.
5. Amoura Z, Choukroun G, Royer I, Gayraud M, Guillevin L. Treatment of systemic diseases with pulse cyclophosphamide: 15 cases. Ann Med Intern Paris. 141:1990;416-420.
6. Brody M, Bohm I, Biwer E, Bauer R. Successful treatment of panarteritis nodosa with low-dose methotrexate therapy. Hautarzt. 45:1994;476-479.
7. Guillevin L, Lhote F, Leon A, Fauvella F, Vivitski L, Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with anti-viral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol. 20:1993;289-298.
8. Fauvelle F, Leon A, Nicolas P, Tod M, Guillevin L, Petitjean O. Pharmacokinetics of vidarabine in the treatment of polyarteritis nodosa. Fundam Clin Pharmacol. 6:1982;11-15.
9. Guillevin L, Lhote F, Sauvaget F, Deblois P, Rossi F, Levallois D, Pourrat J, Christoforov B, Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis. 53:1994;334-337.
10. Hachulla E, Colombel JF, Paris JC, Dracon E. Treatment with interferon alpha and plasma exchange of periarteritis nodosa associated with acute viral hepatitis B. Rev Med Intern. 14:1993;891-892.
11. Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong D, Bussel A, Leon A. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum. 35:1992;208-215.
12. Earnshaw DL, Bacon TH, Darlison SJ, Edmonds K, Perkins RM, Vere Hodge R. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother. 36:1992;2747-2757.
13. Vere Hodge R, Sutton D, Boyd MR, Harnden MR, Jarvest RL. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpes virus agent BRL 39123 (9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir). Antimicrob Agents Chemother. 33:1989;1765-1773.
14. Korba BE, Milman G. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res. 15:1991;217-228.
15. Saltzman R, Jurewicz R, Boon R. Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrob Agents Chemother. 38:1994;2454-2457.
16. Tsiquaye KN, Slomka MJ, Maung M. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo. J Med Virol. 42:1994;306-310.
17. Main J, Brown J, Karayiannis P, Georgiou P, Boyd M, Prince W, Thomas H. A double-blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. (Poster P1C1/38) J Hepatol. 21:1994;S32A. (abstract).
18. Pue MA, Pratt SK, Fairless AJ, Fowless S, Laroche J, Georgiou P, Prince W. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. J Antimicrob Chemother. 33:1994;119-127.
19. Shaw T, Amor P, Civitico G, Boyd M, Locarnini S. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother. 38:1994;719-723.
20. Böker KH, Ringe B, Krüger M, Pichlmayr R, Manns MP. Prostaglandin E plus famciclovir - a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation. 57:1994;1706-1708.
21. Krüger M, Tillmann H, Trautwein C, Oldhafer K, Böker K, Pichlmayr R, Manns M. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation - a pilot study. Liver Transplantation and Surgery. 2:1996;253-262.
22. Tillman H, Trautwein C, Walker D, Michitaka K, Kubicka S, Böker K, Manns M. Clinical relevance of mutations in the precore genome of the hepatitis B virus. Gut. 37:1995;568-573.
23. Wood RP, Rikkers LF, Shaw BJ, Williams L. A review of liver transplantation for gastroenterologists. Am J Gastroenterol. 82:1987;593-606.